A radioisotope technetium-99m (99mTc) has been used widely for the examination and diagnosis of
cancer. 99mTc is obtained as the radioactive decay product of molybdenum-99
(99Mo, half-life: 66 hours), which is produced by irradiating natural
molybdenum or uranium with neutrons in nuclear reactors. As the
half-life of 99mTc is short, 99Mo is made into a "Generator" from which 99mTc is separated and made into radio-pharmaceuticals at the medical
site. The generator, shown in Fig. 3-13, consists of 99Mo adsorbed on an alumina adsorbent in a glass tube. 99mTc can be obtained by passing a physiological saline solution
through the tube. Today 99Mo produced from uranium and having a very low ratio of 99Mo to non-radioactive molybdenum is used because of the poor adsorbability
of alumina to molybdenum. The production of 99Mo from uranium has large difficulties such as the requirement
of heavily shielded production facilities, the evolution of large
quantities of radioactive wastes etc.. An epoch-making adsorbent
for alumina has been developed. Zirconium chloride was allowed
to react with an alcohol and treated thermally to form a novel
high polymer zirconium compound. This compound adsorbs 99Mo 100 times as much as alumina does. Whereas the yield of 99mTc is larger than 80% (Fig. 3-14), the desorption of 99Mo is less than 0.1%. For the sake of such characteristics, this
adsorbent can be used for the preparation of the generator by
using 99Mo easily produced by irradiating natural molybdenum. Practical
applications of the adsorbent are expected. |